Teitur Trophics
Teitur Trophics is a biotech company in Aarhus, Denmark, founded in 2020. It has raised $32.7M across 1 round, most recently a $32.7M Series A in March 2023.
- Headquarters
- Aarhus
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- teiturtrophics.com
- Total Funding
- $32.7M
- Last Round
- $32.7M Series AMar 2023
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Teitur Trophics develops neuroprotective peptides for people affected by neurodegenerative diseases. Its lead asset, TT-P34, is designed to improve mitochondrial and lysosomal function through a dual mechanism of action. This approach targets a pathway underlying multiple aspects of disease pathology, with potential applications in Parkinson’s disease, frontotemporal dementia, and Huntington’s disease.
Summary
It lists 11–50 employees. It has raised $32.7M in total across 1 round, most recently a $32.7M Series A round in Mar 2023.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2023
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/teitur-trophics"><img src="https://indexed.vc/api/badge/company/teitur-trophics" alt="Teitur Trophics on Indexed.vc" width="260" height="76" /></a>